Aldeyra Therapeutics EPS - Earnings per Share 2014-2019 | ALDX

Aldeyra Therapeutics eps - earnings per share from 2014 to 2019. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Aldeyra Therapeutics Annual EPS
2018 $-1.79
2017 $-1.40
2016 $-1.65
2015 $-1.40
2014 $-3.09
2013 $-17.61
Aldeyra Therapeutics Quarterly EPS
Q3 2019 $-0.69
Q2 2019 $-0.49
Q1 2019 $-0.58
Q4 2018 $-0.38
Q3 2018 $-0.52
Q2 2018 $-0.46
Q1 2018 $-0.43
Q4 2017 $-0.36
Q3 2017 $-0.32
Q2 2017 $-0.35
Q1 2017 $-0.37
Q4 2016 $-0.35
Q3 2016 $-0.38
Q2 2016 $-0.41
Q1 2016 $-0.51
Q4 2015 $-0.46
Q3 2015 $-0.35
Q2 2015 $-0.27
Q1 2015 $-0.32
Q4 2014 $2.87
Q3 2014 $-0.36
Q2 2014 $-1.56
Q1 2014 $-4.04
Q4 2013 $10.70
Q3 2013 $-9.81
Q2 2013 $-5.47
Q1 2013 $-13.03
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.133B $0.000B
Aldeyra Therapeutics, Inc. is a biotechnology company. The company's products target immune-mediated, inflammatory, orphan, and other diseases. It is developing NS2, a compound that binds and traps free aldehydes. Aldeyra Therapeutics, Inc. is based in Burlington, Massachusetts.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $63.808B 10.08
Zoetis (ZTS) United States $57.032B 34.11
Astellas Pharma (ALPMY) Japan $31.827B 15.90
Eisai (ESALY) Japan $20.681B 39.88
UCB SA (UCBJF) Belgium $15.697B 0.00
Grifols, S.A (GRFS) Spain $15.415B 20.20
Merck (MKGAF) Germany $14.688B 20.04
Neurocrine Biosciences (NBIX) United States $10.920B 515.52
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $9.301B 0.00
Ionis Pharmaceuticals (IONS) United States $9.143B 18.52
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.382B 10.70
Sage Therapeutics (SAGE) United States $7.732B 0.00
Catalent (CTLT) United States $7.576B 30.82
Arrowhead Pharmaceuticals (ARWR) United States $6.361B 96.32
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.263B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $4.846B 17.42
FibroGen (FGEN) United States $4.082B 119.95
United Therapeutics (UTHR) United States $4.008B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.650B 13.34
Nektar Therapeutics (NKTR) United States $3.570B 0.00
Evotec AG (EVTCY) Germany $3.226B 52.78
PTC Therapeutics (PTCT) United States $3.086B 0.00
Heron Therapeutics (HRTX) United States $2.382B 0.00
Xencor (XNCR) United States $2.301B 69.95
Portola Pharmaceuticals (PTLA) United States $2.205B 0.00
Zogenix (ZGNX) United States $2.071B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.932B 57.16
Ironwood Pharmaceuticals (IRWD) United States $1.929B 61.50
Tilray (TLRY) Canada $1.886B 0.00
ChemoCentryx (CCXI) United States $1.630B 0.00
USANA Health Sciences (USNA) United States $1.609B 17.17
Corcept Therapeutics (CORT) United States $1.501B 18.24
Endo (ENDP) Ireland $1.248B 2.29
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.239B 28.28
Theravance Biopharma (TBPH) Cayman Islands $1.225B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.211B 8.27
Karyopharm Therapeutics (KPTI) United States $1.133B 0.00
ArQule (ARQL) United States $1.123B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.070B 0.00
Radius Health (RDUS) United States $1.003B 0.00
Aerie Pharmaceuticals (AERI) United States $0.940B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.791B 0.00
Akebia Therapeutics (AKBA) United States $0.714B 0.00
Flexion Therapeutics (FLXN) United States $0.709B 0.00
Collegium Pharmaceutical (COLL) United States $0.692B 0.00
TherapeuticsMD (TXMD) United States $0.659B 0.00
ImmunoGen (IMGN) United States $0.599B 0.00
Translate Bio (TBIO) United States $0.597B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.478B 58.00
Molecular Templates (MTEM) United States $0.471B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.470B 0.00
Organogenesis Holdings (ORGO) United States $0.457B 0.00
Harpoon Therapeutics (HARP) United States $0.443B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.440B 0.00
Dermira (DERM) United States $0.437B 0.00
Ardelyx (ARDX) United States $0.429B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.418B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.407B 17.55
DURECT (DRRX) United States $0.396B 0.00
Indivior (INVVY) United States $0.393B 1.42
Recro Pharma (REPH) United States $0.379B 0.00
Concordia (CXRXF) Canada $0.374B 0.00
OptiNose (OPTN) United States $0.370B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.359B 0.00
Innate Pharma SA (IPHYF) France $0.358B 0.00
Siga Technologies (SIGA) United States $0.357B 8.15
Lannett Co Inc (LCI) United States $0.349B 4.06
Corbus Pharmaceuticals Holdings (CRBP) United States $0.329B 0.00
Rafael Holdings (RFL) United States $0.286B 0.00
KalVista Pharmaceuticals (KALV) United States $0.266B 0.00
GlycoMimetics (GLYC) United States $0.264B 0.00
Jounce Therapeutics (JNCE) United States $0.263B 3.51
Calithera Biosciences (CALA) United States $0.252B 0.00
Xeris Pharmaceuticals (XERS) United States $0.241B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.229B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.222B 0.00
Aquestive Therapeutics (AQST) United States $0.220B 0.00
Ocular Therapeutix (OCUL) United States $0.196B 0.00
Nature's Sunshine Products (NATR) United States $0.190B 32.73
Foamix Pharmaceuticals (FOMX) Israel $0.189B 0.00
Concert Pharmaceuticals (CNCE) United States $0.181B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
MEI Pharma (MEIP) United States $0.147B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.146B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.145B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.142B 0.00
IMV INC (IMV) Canada $0.140B 0.00
Redhill Biopharma (RDHL) Israel $0.139B 0.00
CannTrust Holdings (CTST) Canada $0.110B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Cardiome Pharma (CORV) Canada $0.102B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.100B 0.00
CV Sciences (CVSI) United States $0.099B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.091B 0.00
Champions Oncology (CSBR) United States $0.081B 0.00
MediWound (MDWD) Israel $0.080B 0.00
PolarityTE (PTE) United States $0.080B 0.00
Otonomy (OTIC) United States $0.079B 0.00
Neos Therapeutics (NEOS) United States $0.079B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.078B 23.45
Infinity Pharmaceuticals (INFI) United States $0.072B 0.00
Aclaris Therapeutics (ACRS) United States $0.070B 0.00
Capnia (SLNO) United States $0.068B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.066B 0.00
Pharmaxis (PXSLY) Australia $0.065B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.059B 0.00
Genocea Biosciences (GNCA) United States $0.059B 0.00
Novan (NOVN) United States $0.057B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.056B 0.00
SCYNEXIS (SCYX) United States $0.056B 0.00
Natural Alternatives (NAII) United States $0.056B 13.93
Nivalis Therapeutics (ALPN) United States $0.056B 0.00
Medicure (MCUJF) Canada $0.054B 0.00
CTI BioPharma (CTIC) United States $0.053B 0.00
RENEURON GP (RNUGF) United Kingdom $0.052B 0.00
IntelGenx Technologies (IGXT) Canada $0.052B 0.00
ElectroCore (ECOR) United States $0.051B 0.00
Mast Therapeutics (SVRA) United States $0.049B 0.00
AgeX Therapeutics (AGE) United States $0.047B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.047B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.042B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.041B 0.00
IsoRay (ISR) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Opexa Therapeutics (ACER) United States $0.037B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.035B 0.00
PharmAthene (ALT) United States $0.033B 0.00
Jaguar Animal Health (JAGX) United States $0.031B 0.00
Biomerica (BMRA) United States $0.029B 0.00
India Globalization Capital (IGC) United States $0.029B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.027B 0.00
ProPhase Labs (PRPH) United States $0.025B 0.00
Bio-Path Holdings (BPTH) United States $0.024B 0.00
Melinta Therapeutics (MLNT) United States $0.023B 0.00
Shineco (TYHT) China $0.023B 0.00
China SXT Pharmaceuticals (SXTC) China $0.022B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
VAXART, INC (VXRT) United States $0.015B 0.00
Heat Biologics (HTBX) United States $0.015B 0.00
Vical (BBI) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Lipocine (LPCN) United States $0.011B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Achieve Life Sciences (ACHV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Can-Fite Biopharma (CANF) Israel $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Hemispherx BioPharma (AIM) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Forward Pharma (FWP) Denmark $0.000B 0.00